Recipient
 Funding year(s)

Mentor

Project Title

Billy Kim, M.D.
1,2

DFCI/
Kaelin

Determining the Role of HIF1   and HIF2 in VHL associated tumorigenesis

Pankaj Seth, Ph.D.
1,2

BIDMC/
 Sukhatme

Gene Profiling of Renal Cancer Cell Endothelium

Won Han, M.D.
3

BWH/
Bonventre

Human Kidney Cancer Injury Molecule-1 in RCC

Robert Ross, M.D.
3*, 4, 5

MGH-DFCI/
Weisleder

Evaluation of the response and resistance of kidney cancer to VEGF and/or mTor-pathway inhibitor with MION-enhanced MRI

Daniel Cho, M.D.
4, 5

BIDMC/
Atkins- Mier

Enhancing the efficacy of sorafenib and sunitinib in the treatment of advanced RCC by concurrent inhibition of additional kinases

Lianjie Li, Ph.D
4, 5

DFCI/
Kaelin

The biochemichal analysis of the differential risk of RCC associated with Type 2A and Type 2B vHL disease

Kevin Courtney, M.D, Ph.D.
(Genentech) 05S1

DFCI BIDMC
Cantley

Evaluation of phosphoinositide 3-kinase (PI3K) and CXCR4 activation in renal cell carcinoma

Rupal Bhatt, M.D. (Pfizer)
05S1

BIDMC/
Mier

The balance of angiogenesis and angiostasis determines response and resistance to antiangiogenic therapies.

Michael Zimmer, Ph.D. (Pfizer)
05S1

MGH/
Iliopoulos

Small molecule screen uncovers IRP1-mediated HIF translational repression